A recent breakthrough by researchers from the UK and Israel has unveiled the genetic basis of the AnWj blood group, resolving a 50-year-old mystery and potentially enhancing blood transfusion safety for rare blood type patients.
In a significant advancement for transfusion medicine, a collaborative research team from the United Kingdom and Israel has identified the genetic underpinnings of the elusive AnWj blood group, concluding a scientific inquiry that has persisted for over five decades. This discovery introduces a new blood group system known as MAL, which could enhance the safety and efficacy of blood transfusions worldwide, particularly for individuals with rare blood types.
The research, primarily conducted by NHS Blood and Transplant through its International Blood Group Reference Laboratory (IBGRL) in Bristol, involved partnerships with the University of Bristol and various international collaborators. The findings were published in the esteemed journal Blood, a publication of the American Society of Hematology, marking a crucial milestone in the field.
Understanding Blood Groups
Human blood types are commonly classified as A, B, AB, or O, in addition to the Rh factor. However, these familiar classifications represent only a fraction of the complexities inherent in human blood. Currently, scientists recognize 47 distinct blood group systems, which encompass over 360 unique blood antigens. These antigens are critical molecules located on the surface of red blood cells, and even minor discrepancies between donors and recipients can provoke severe immune reactions during transfusions.
The AnWj antigen, which is central to the newly acknowledged MAL blood group system, was first identified in 1972. Its designation—AnWj—derives from the names of the first individuals discovered to possess the antibody, Anton and Wj. Despite its recognition, the genetic origins of the AnWj antigen remained elusive for more than 50 years, with researchers capable of detecting the antigen but unable to pinpoint the responsible genetic factors.
Decoding the AnWj Mystery
Utilizing whole exome sequencing, a technique that examines all protein-coding regions of DNA, the research team discovered that individuals lacking the AnWj antigen possess deletions in both copies of the MAL gene. This gene is responsible for producing a small membrane protein called Mal, which is involved in maintaining cell membrane stability and facilitating cellular transport. Notably, AnWj-positive individuals express the full-length Mal protein on their red blood cells, while those who are AnWj-negative do not.
To validate their findings, the researchers introduced the normal MAL gene into laboratory blood cell lines, which subsequently began producing the AnWj antigen. Conversely, mutated versions of the gene failed to elicit the antigen, providing compelling evidence that the Mal protein is directly associated with the AnWj blood group. This study also put to rest previous hypotheses that linked the AnWj blood type to other genetic factors.
The Significance of the Discovery
Although more than 99.9% of the population is AnWj-positive, the small fraction of individuals who are AnWj-negative face significant risks if they receive incompatible blood during transfusions, which can result in severe immune reactions. Historically, identifying these individuals has been challenging due to the unknown genetic basis of the blood group.
The identification of the MAL blood group system paves the way for the development of new genetic tests aimed at recognizing rare donors and patients prior to transfusions. Researchers anticipate that these tests could be integrated into existing blood typing methodologies, thereby streamlining the process of matching blood types. This innovation is particularly crucial since many AnWj-negative cases are not inherited; certain medical conditions, including specific blood disorders and cancers, can temporarily suppress the Mal protein, leading to a false appearance of being AnWj-negative.
The inherited form of the AnWj-negative trait appears to be exceedingly rare, with the study identifying only five genetically AnWj-negative individuals. This includes members of an Arab-Israeli family, and researchers suggest that there may be additional undiagnosed cases globally, especially now that genetic testing is feasible. Importantly, individuals born with the inherited MAL deletion are otherwise healthy, underscoring the need for further research in this area.
Implications for the Future of Transfusion Medicine
This breakthrough represents a culmination of efforts spanning nearly 20 years by Louise Tilley, Senior Research Scientist at NHS Blood and Transplant, who has dedicated much of her career to unraveling the genetic complexities surrounding the AnWj blood group. Tilley emphasized the significance of this achievement, stating, “The genetic background of AnWj has been a mystery for more than 50 years, and one which I personally have been trying to resolve for almost 20 years of my career.”
Prof. Ash Toye from the University of Bristol highlighted the transformative power of modern genetic tools in advancing transfusion medicine, noting, “It’s really exciting we were able to use our ability to manipulate gene expression in the developing blood cells to help confirm the identity of the AnWj blood group, which has been an outstanding puzzle for half a century.”
Furthermore, Nicole Thornton, Head of the IBGRL Red Cell Reference at NHS Blood and Transplant, described the investigation as one of the organization’s most daunting challenges, reiterating the passion for producing discoveries that benefit patients with rare blood types globally.
The International Society of Blood Transfusion (ISBT) has officially recognized MAL as the 47th blood group system, underscoring its importance in the ongoing evolution of transfusion science.
The Growing Importance of Rare Blood Research
As personalized medicine continues to evolve, the identification of rare blood types is becoming increasingly critical. Patients with uncommon blood groups often rely on specially matched donors, sometimes necessitating international coordination to secure compatible blood. Blood banks worldwide maintain rare donor registries to facilitate these matches during emergencies and complex medical procedures.
Researchers assert that discoveries like MAL are vital in reducing the number of unexplained blood antigens, thereby enhancing transfusion safety and furthering our understanding of human genetics.
For reference, the study titled “Deletions in the MAL gene result in loss of Mal protein, defining the rare inherited AnWj-negative blood group phenotype” was authored by Louise A Tilley and colleagues, and published on August 18, 2024, in Blood.
No Comment! Be the first one.